Skip to main content
. 2010 Aug 31;103(7):954–960. doi: 10.1038/sj.bjc.6605856

Figure 1.

Figure 1

Changes of mean plasma (A) arginine and (B) citrulline levels, and (C) plasma titres of anti-ADI antibody after weekly administration of either 160 or 320 IU m−2 ADI-PEG 20 in patients with unresectable HCC.